BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1196703)

  • 1. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
    Watts RW; Chalmers RA; Liberman MM; Lawson AM
    Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K; Matolon R; Wong PW
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.
    Gentz J; Lindblad B; Lindstedt S; Zetterström R
    J Lab Clin Med; 1969 Aug; 74(2):185-202. PubMed ID: 5799507
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic studies on two patients with nonhepatic tyrosinemia using deuterated tyrosine loads.
    Faull KF; Gan I; Halpern B; Hammond J; Im S; Cotton RG; Danks DM; Freeman R
    Pediatr Res; 1977 May; 11(5):631-7. PubMed ID: 870870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary phenolic acids in tyrosinemia. Identification and quantitation by gas chromatography-mass spectrometry.
    Crawhall JC; Mamer O; Tjoa S; Claveau JC
    Clin Chim Acta; 1971 Aug; 34(1):47-54. PubMed ID: 5118727
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Ellis MK; Whitfield AC; Gowans LA; Auton TR; Provan WM; Lock EA; Smith LL
    Toxicol Appl Pharmacol; 1995 Jul; 133(1):12-9. PubMed ID: 7597701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosyluria in marasmus.
    Dhatt PS; Saini AS; Gupta I; Mehta HC; Singh H
    Br J Nutr; 1979 Nov; 42(3):387-90. PubMed ID: 116674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exceptional case of tyrosinosis.
    Wadman SK; van Sprang FJ; Maas JW; Ketting D
    J Ment Defic Res; 1968 Dec; 12(4):269-81. PubMed ID: 5729527
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simple method for study of tyrosyluria].
    Humbel R
    Pharm Acta Helv; 1968 Jan; 43(1):57-64. PubMed ID: 5719458
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.
    Curtius HC; Völlmin JA; Baerlocher K
    Clin Chim Acta; 1972 Mar; 37():277-85. PubMed ID: 5022091
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Mitchell GA
    Hum Exp Toxicol; 1996 Feb; 15(2):179-81. PubMed ID: 8645506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diet in phenylketonuria].
    Richardet JM; Brissaud HE; Raynaud J; Repesse G; Galli J
    Arch Fr Pediatr; 1969; 26(7):791-807. PubMed ID: 5355253
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic studies of transient tyrosinemia in premature infants.
    Fernbach SA; Summons RE; Pereira WE; Duffield AM
    Pediatr Res; 1975 Apr; 9(4):172-6. PubMed ID: 1143952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatic acid excretion in classical phenylketonuria and hyperphenylalaninemic variants.
    Koepp P; Hoffmann B
    Helv Paediatr Acta; 1974 Nov; 29(5):489-98. PubMed ID: 4452644
    [No Abstract]   [Full Text] [Related]  

  • 17. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
    Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
    Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.
    Suzuki Y; Konda M; Imai I; Imamura H; Shimao S; Okaka T
    Int J Pediatr Nephrol; 1987; 8(3):171-6. PubMed ID: 3429140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vivo function of glucagon-induced phenylalanine: pyruvate transaminase in p-chlorophenylalanine-treated rats.
    Shih JC; Lien CC; Malcolm RD
    Arch Biochem Biophys; 1982 Apr; 215(1):66-71. PubMed ID: 6212025
    [No Abstract]   [Full Text] [Related]  

  • 20. Promising new treatment for type I tyrosinemia.
    Heubi JE
    J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):340-1. PubMed ID: 8271141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.